MedPath

Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD)

Completed
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT01527773
Lead Sponsor
University of Zurich
Brief Summary

TOPDOCS is a prospective cohort study including COPD patients from currently six study centers in Switzerland. Patients with COPD GOLD stages I-IV will be enrolled and followed-up annually for at least 3 years. Yearly assessments will include a detailed patient history, quality of life and activity questionnaires, history of exacerbations, lung function, measurements of exercise capacity, measurements of vascular function, exhaled breath analysis and blood sampling. The overall objective of the project is to establish a meticulously characterized cohort of COPD patients living in Switzerland in order to allow high quality research on the pathogenesis, treatment and complications of COPD. The specific aim of the project is to determine clinically relevant COPD phenotypes and biological factors influencing vascular function in COPD patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
313
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Lung functionThe change from baseline in lung function at 3 years

FEV1

Secondary Outcome Measures
NameTimeMethod
ExacerbationsThe number of exacerbations observed within 3 years

Number of COPD exacerbations observed within 3 years of observation

Hear Arterial StiffnessThe change from baseline in arterial stiffness at 3 years

Arterial stiffness by pulse wave analysis

Endothelial FunctionThe change from baseline in endothelial function at 3 years

Endothelial function assessed by flow-mediated dilatation (FMD)

Exercise capacityThe change from baseline in exercise capacity at 3 years

6 minute walking test and sit-to-stand test

Quality of lifeThe change from baseline in quality of life scale at 3 years

Quality of life scales

Blood pressureThe change from baseline in mean blood pressure at 3 years

Mean blood pressure

Cardiovascular risk scoreThe change from baseline in risk score function at 3 years

Pocock score

ActivityThe change from baseline in activity at 3 years

Actigraphy

BODE-indexThe change from baseline in BODE-index at 3 years

BODE-Index

Trial Locations

Locations (1)

University Hospital Zurich, Pneumology

🇨🇭

Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath